Opendata, web and dolomites

CaReSyAn SIGNED

Combatting the CardioRenal Syndrome: towards an integrative Analysis to reduce cardiovascular burden in chronic kidney disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CaReSyAn project word cloud

Explore the words cloud of the CaReSyAn project. It provides you a very rough idea of what is the project "CaReSyAn" about.

patient    caused    caresyan    kidneys    strives    services    disciplinary    synergistically    functional    patients    crs    complementary    cardiovascular    environments    business    bioinformatical    pathology    young    successfully    builds    bioinformatics    generate    cooperations    therapy    treatment    trained    broadly    technological    heart    structural    45    cornerstone    integrate    chronic    methodically    disease    close    ongoing    cardiorenal    ckd    animals    scientists    socio    experimental    vitro    cvd    innovative    kidney    bridge    skills    personal    extend    diagnosis    cooperation    mechanistic    translation    industry    extremely    bridges    sme    combatting    integrating    training    deaths    programs    disorders    solely    nurture    proteomics    technologies    entrepreneurs    killer    syndrome    career    exactly    century    vessels    excellent    basic    clinical    academic    molecular    economic    train    diseases    academia    insights    scientific    exposure    burden    cohorts   

Project "CaReSyAn" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAETSKLINIKUM AACHEN 

Organization address
address: Pauwelsstrasse 30
city: AACHEN
postcode: 52074
website: www.ukaachen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 2˙795˙346 €
 EC max contribution 2˙795˙346 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2017
 Funding Scheme MSCA-ITN-ETN
 Starting year 2018
 Duration (year-month-day) from 2018-01-01   to  2021-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAETSKLINIKUM AACHEN DE (AACHEN) coordinator 747˙649.00
2    KAROLINSKA INSTITUTET SE (STOCKHOLM) participant 263˙659.00
3    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) participant 262˙875.00
4    RD NEPHROLOGIE SAS FR (MONTPELLIER) participant 262˙875.00
5    MEDIZINISCHE UNIVERSITAET WIEN AT (WIEN) participant 255˙934.00
6    DSM MATERIALS SCIENCE CENTER BV NL (GELEEN) participant 255˙374.00
7    UNIVERSITEIT MAASTRICHT NL (MAASTRICHT) participant 255˙374.00
8    MOSAIQUES DIAGNOSTICS GMBH DE (HANNOVER) participant 249˙216.00
9    IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON EL (ATHINA) participant 242˙386.00
10    DSM R & D SOLUTIONS BV NL (SITTARD) participant 0.00
11    "EUTox, working group of the ""European Society of Artificial Organs"" (ESAO)" AT (Krems) partner 0.00
12    Bayer Pharma AG DE (Berlin) partner 0.00
13    Fresenius Medical Care Deutschland GmbH DE (BAD HOMBURG) partner 0.00
14    INSTITUTO INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ ES (MADRID) partner 0.00
15    KATHOLIEKE UNIVERSITEIT LEUVEN BE (LEUVEN) partner 0.00

Map

 Project objective

Successfully combatting a complex disease requires multi-disciplinary and methodically well-trained scientists. CaReSyAn strives to accomplish exactly this: we will train scientists to successfully integrate proteomics, clinical, experimental and bioinformatical analyses to enhance the understanding, diagnosis and therapy of the cardiorenal syndrome (CRS). CRS comprises disorders of the heart, vessels and kidneys, including the increased development of cardiovascular disease (CVD) in patients with chronic kidney disease (CKD). With ~45% of all deaths in CKD patients caused by CVD, the socio-economic burden of CRS is extremely high.

CaReSyAn will train scientists in a close cooperation between academia, SME and industry partners. Key objectives are to provide: 1) Excellent scientific training on CRS pathology, integrating clinical/mechanistic knowledge with technological skills (animals and in vitro, molecular and functional studies, proteomics and bioinformatics) to generate innovative insights triggering the understanding, diagnosis and treatment of the CRS; 2) Excellent complementary skills in personal and career development as well as business training required to extend beyond scientific research; and 3) Exposure to both academic and non-academic environments, required to build bridges between researchers and entrepreneurs and support the future translation of research findings in innovative products and services. CaReSyAn builds on already available patient cohorts, advanced technologies and established cooperations. CaReSyAn is complementary to ongoing European programs focusing solely on CKD or CVD and strives to synergistically improve structural training on European level. CaReSyAn will nurture the development of young, broadly-trained scientists able to successfully bridge clinical with basic research as well as academia and industry. This is a cornerstone in effectively combatting complex diseases as CRS, a major killer of this century.

 Publications

year authors and title journal last update
List of publications.
2019 Eleni Petra, Jerome Zoidakis, Antonia Vlahou
Protein biomarkers for cardiorenal syndrome
published pages: 325-336, ISSN: 1478-9450, DOI: 10.1080/14789450.2019.1592682
Expert Review of Proteomics 16/4 2020-04-09
2019 Tianlin He
Implementation of Proteomics in Clinical Trials
published pages: 1800198, ISSN: 1862-8346, DOI: 10.1002/prca.201800198
PROTEOMICS – Clinical Applications 13/2 2020-04-09
2019 Sam Hobson, Samsul Arefin, Karolina Kublickiene, Paul Shiels, Peter Stenvinkel
Senescent Cells in Early Vascular Ageing and Bone Disease of Chronic Kidney Disease—A Novel Target for Treatment
published pages: 82, ISSN: 2072-6651, DOI: 10.3390/toxins11020082
Toxins 11/2 2020-04-09
2019 Julie Klein, Joost P Schanstra
Implementation of Proteomics Biomarkers in Nephrology: From Animal Models to Human Application?
published pages: 1800089, ISSN: 1862-8346, DOI: 10.1002/prca.201800089
PROTEOMICS – Clinical Applications 13/2 2020-04-09

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CARESYAN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CARESYAN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

DISTINCT (2019)

Dementia: Intersectorial Strategy for Training and Innovation Network for Current Technology (DISTINCT)

Read More  

BIGMATH (2018)

Big Data Challenges for Mathematics

Read More  

POLISS (2019)

Policies for Smart Specialisation

Read More